[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after
More
[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with
MoreThe U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all
More
[column]Two mutations central to the development of infantile myofibromatosis (IM) – a disorder characterized by multiple tumors involving
More
[column]Advances in genetic profiling have allowed doctors to match more of their cancer patients with treatments that will target their
More
4 symposiums on Oncology, General Biologics, Immunology and Cardiology at 6th annual BioPharma Asia Convention 2013. Research on Oncology, Cardiology, Immunology and
More